Activity value 80International Buyer&Supplier,Last transaction date:
2025-12-18
Overview
Import data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for fic ls geeta pharma from 2024 to 2025.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2025, the company has completed 24 transactions, with a transaction quantity of 243077 and a transaction weight of 0.
YearTransactionsQuantityWeight
2024000
2025242430770
Bill of lading data
<
1/15
>
Trade date
2025/12/18
B/L No.
7855726
Suppliers
unosource pharma ltd.
Buyers
fic ls geeta pharma
Product description
PHARMACEUTICAL PRODUCTS MEDICINE AKUROSEINJ IRON SUCROSE INJ
Expand
+View All
Products
Total 618
ProductsTransactionsPerDetail
dehydrated culture media 114883.8%>
supplements 109980.22%>
chemical 59443.36%>
amino 856.2%>
injection 705.11%>
+View All
Hscode rank
Total 297
HSCode NameTransactionsPerDetail
HS 3822909021815.91%>
HS 3821000015711.46%>
HS 3004909914110.29%>
HS 32129090282.04%>
HS 28352200251.82%>
+View All
Trading Area
Total 2
AreaTransactionsPerDetail
india445399.91%>
russia40.09%>
Port statistics
Total 3
Port NameTransactionsPerDetail
tashkent438598.38%>
bandar abbas180.4%>
qingdao60.13%>
fic ls geeta pharma is International Buyer&Supplier,
and primarily engages in the import and export business of products such as dehydrated culture media,supplements,chemical.
According to the 52wmb.com global trade database, as of 2025-12-18, the company has completed 4458 international trades,
with its main trading regions covering india,russia etc.
The core products include HS38229090,HS38210000,HS30049099 etc,
often transported via tashkent,port bandar abbas, port qingdao etc,
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on fic ls geeta pharma is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.